๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Qingdao
Clinical trial register · China

Clinical Trials in Qingdao, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
The Affiliated Hospital of Qingdao University30 Tianjin Medical University17 Qilu Hospital of Shandong University7 Qingdao Central Hospital7 Shandong University3
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to

Trials with a site in Qingdao

165 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Study of Efficacy and Safety of FRSW107 in Pediatric Patients With Severe Hemophilia A
NCT06136507Severe Hemophilia A
Hangzhou Gensciences Biopharmaceutical Co., Ltd.
Phase 3
76
Chongqing, Guangzhou, Guizhou, Hangzhou, Hefei, Nanjing, Qingdao, Shenzhen
2026-12-25
Recruiting
Glycoprotein IIb/IIIa PET/CT in Various GPIIb/IIIa-Related Disease
NCT07813559Thrombi, Thrombus, Brain, Thrombus
Tianjin Medical University
Observational
500
Hefei, Qingdao, Tianjin
2026-09-01
Not yet open
The Correlation Between Sodium Urate (MSU) Deposition and Coronary Atherosclerosis in Patients With Foot Gout
NCT07784049Gout, Coronary Atheroma
The Affiliated Hospital of Qingdao University
Observational
200
Qingdao
2026-08-20
Recruiting
Evaluation of Fecal Multi-target Biomarkers in the Screening of Digestive Tract Cancers
NCT07600125Gastric Cancer, Colorectal Cancer
Xijing Hospital
Observational
5,000
Xi'an, Dalian, Hami, Heze, Jinan, Langfang, Liuโ€˜an, Qingdao
2026-08-10
Not yet open
Home-based Whole Course Multimodal Prehabilitation Based on 5G + Artificial Intelligence Mobile Health
NCT07764523Gastric Cancer, Prehabilitation
The Affiliated Hospital of Qingdao University
Not applicable
328
Qingdao
2026-08-01
Not yet open
Prophylactic IABP in Delayed-Presentation Anterior STEMI
NCT07761455Acute Anterior ST-Segment Elevation Myocardial Infarction
Qilu Hospital of Shandong University
Not applicable
504
Jinan, Jining, Qingdao, Beijing
2026-08-01
Not yet open
Multimodal Prehabilitation for Tumor-Related Bowel Obstruction
NCT07767760Malignant Tumor, Prehabilitation
The Affiliated Hospital of Qingdao University
Not applicable
394
Qingdao
2026-08-01
Not yet open
The Efficacy and Safety of Donafenib Plus PD-1/L1 Monoclonal Antibodies Plus TACE or HAIC as First-line Treatment for Unresectable Hepatocellular Carcinoma A Multi-center, Retrospective Clinical Study
NCT07724951Hepatocellular Carcinoma (HCC)
Shanghai Zhongshan Hospital
Observational
400
Guangzhou, Nanning, Harbin, Qingdao, Shanghai, Kunming
2026-07-31
Not yet open
TEAS Timing for Gastrectomy Recovery (TEAS-TIME Trial)
NCT07714980Gastric Cancer (GC), Stomach Neoplasms
The Affiliated Hospital of Qingdao University
Not applicable
300
Dongying, Qingdao, Rizhao, Weifang, Weihai, Yantai
2026-07
Not yet open
A Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy
NCT07676266Multiple Sclerosis (MS), Myasthenia Gravis (MG), Neuromyelitis Optica Spectrum Disorder, Systemic Lupus Erythematosus
The Affiliated Hospital of Qingdao University
Phase 1
18
Qingdao
2026-07
Not yet open
A Clinical Study to Evaluate the Effect of Different Dosing Conditions on the Pharmacokinetics of HRS9531 Tablets in Healthy Participants
NCT06506175Weight Management, Type 2 Diabetes
Fujian Shengdi Pharmaceutical Co., Ltd.
Phase 1
100
Qingdao
2026-07
Not yet open
Intraarterial Therapies Plus Tislelizumab Plus Lenvatinib Versus Tislelizumab Plus Gemcitabine-Cisplatin in Unresectable Intrahepatic Cholangiocarcinoma
NCT07691515Intrahepatic Cholangiocarcinoma (Icc)
Zhejiang Cancer Hospital
Phase 3
140
Guangzhou, Jiangmen, Wuhan, Changsha, Ganzhou, Nanchang, Qingdao, Chengdu
2026-07
Recruiting
Monoamine Oxidase A PET/CT in Various MAO-A-Related Disease
NCT07685860Depression, Anxiety, Heart Injuries
Tianjin Medical University
Observational
200
Hefei, Qingdao, Tianjin
2026-06-25
Recruiting
Monoamine Oxidase B PET/CT in Various MAO-B-Related Disease
NCT07685873Parkinson Disease, Parkinson Disease Dementia, Parkinson's Disease and Parkinsonism
Tianjin Medical University
Observational
200
Hefei, Qingdao, Tianjin
2026-06-25
Recruiting
Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple Myeloma
NCT07555938Multiple Myeloma
Hoffmann-La Roche
Phase 3
380
Guangzhou, Nanjing, Qingdao, Kunming, Hangzhou, Jinan, Nanning, Shanghai
2026-06-23
By invitation
Predictive Efficacy of Fecal Calprotectin Assay by Magnetic Particle Chemiluminescence for Mucosal Healing in Moderate-to-Severe Ulcerative Colitis Patients Undergoing Initial Biologic Therapy๏ผˆPRECAL๏ผ‰
NCT07721441Ulcerative Colitis (UC)
Tang-Du Hospital
Observational
200
Beijing, Chongqing, Shenzhen, Wuhan, Nanjing, Shengyang, Qingdao, Xiโ€™an
2026-06-18
Recruiting
Programmed Cell Death Ligand 1 PET/CT in Various PD-L1-Related Disease Patients
NCT07618936PD-L1 Gene Mutation, PD-L1 Gene Amplification, PD-L1-related Disease, Positron Emission Tomography
Tianjin Medical University
Observational
500
Hefei, Qingdao, Tianjin
2026-06-01
Not yet open
Molecular Subtype-Guided Postoperative Radiotherapy for Phyllodes Tumor of the Breast: A Randomized Controlled Trial
NCT07657169Radiotherapy, Adjuvant, Phyllodes Breast Tumor, Prognosis, Molecular Typing
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Not applicable
160
Guangzhou, Shenzhen, Jinan, Qingdao
2026-06-01
Not yet open
Neoadjuvant Anlotinib and Epirubicin for T4 Sinonasal Adenoid Cystic Carcinoma
NCT07616141Adenoid Cystic Carcinoma
Eye & ENT Hospital of Fudan University
Phase 2
76
Beijing, Guangzhou, Qingdao, Shanghai
2026-06-01
Recruiting
China Metastatic Liver Cancer Clinical Registry Cohort Database
NCT07602504Liver Metastases, Metastases to Liver, Liver Cancer, Neoplasms
Anhui Provincial Hospital
Observational
2,000
Bengbu, Hefei, Qingdao
2026-06-01
Not yet open
Anlotinib + Benmelstobart vs Surgery for Patients With Localized Renal Cell Carcinoma Scheduled to Undergo Partial Nephrectomy
NCT07627464Renal Cell Carcinoma (RCC)
Tianjin Medical University Cancer Institute and Hospital
Phase 2
144
Beijing, Changchun, Changsha, Hangzhou, Kunming, Nanjing, Nanning, Qingdao
2026-05-31
Recruiting
The Effect of Oral Clostridium Butyricum on the Recurrence After Colonoscopic Resection of Colorectal Adenoma
NCT07167342Colorectal Adenoma, Probiotics
The Affiliated Hospital of Qingdao University
Phase 4
294
Qingdao, Weifang
2026-05-22
Not yet open
A Prospective, Multicenter Exploratory Clinical Study on Consolidation Therapy With Tislelizumab Combined With Nintedanib for Limited-stage Small Cell Lung Cancer
NCT07485920Limited-stage Small Cell Lung Cancer (LS-SCLC)
The Affiliated Hospital of Qingdao University
Phase 4
20
Qingdao, Weihai, Yantai, Zibo
2026-05-01
Not yet open
Covered vs Bare Metal Stents for Atherosclerotic Renal Artery Stenosis
NCT07566065Atherosclerotic Renal Artery Stenosis, Hypertension, Renal Artery Stenosis
Chinese Academy of Medical Sciences, Fuwai Hospital
Not applicable
150
Guangzhou, Harbin, Zhengzhou, Nanjing, Nanchang, Dalian, Jinan, Qingdao
2026-04-30
Active, closed
A Clinical Study Comparing the Bioequivalence of IBI3027 and DUPIXENTยฎ(Dupilumab) in Healthy Chinese Volunteers
NCT07502534Healthy Volunteers
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1
180
Qingdao
2026-04-24
Not yet open
Phase 1 Study of HS-20152 in Healthy Participants
NCT07503015Healthy Volunteers
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Phase 1
32
Qingdao
2026-04-22
Recruiting
RATS Sleeve Lobectomy After Neo-Chemo-IO for NSCLC
NCT07541521Stage IIB-III NSCLC, Sleeve Lobectomy, Robotic Surgery, Neoadjuvant Chemoimmunotherapy
Shanghai Chest Hospital
Observational
100
Fuzhou, Guangzhou, Shenzhen, Nanjing, Qingdao, Tianjing, Shanghai
2026-04-13
Recruiting
A Phase II Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumour[Substudy 04]
NCT07390383Advanced Solid Tumour
Nanjing Leads Biolabs Co.,Ltd
Phase 2
110
Beijing, Shijiazhuang, Jinan, Qingdao, Taiyuan, Tianjin
2026-04-13
Not yet open
Effect of Acupuncture on Psychoneurological Symptom Cluster in Breast Cancer Survivors
NCT07481903Psychoneurological Symptom Cluster(Pain, Insomnia, Anxiety, Fatigue, Depression, Subjective Cognitive Decline), Pain, Insomnia, Anxiety
First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Not applicable
228
Beijing, Nanjing, Qingdao, Tianjin
2026-04
Not yet open
A Clinical Study to Evaluate the Pharmacokinetics and Safety of Anecatibin Fumarate Capsules in Subjects With Impaired Liver Function Versus Normal Liver Function
NCT07538973Lung Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1
24
Xiamen, Zhengzhou, Qingdao
2026-04
Recruiting
Aortic No-Touch vs Partial Aortic Clamping in Off-Pump CABG
NCT07302659Coronary Artery Bypass Graft (CABG)
China National Center for Cardiovascular Diseases
Not applicable
380
Beijing, Qingdao, Shenzhen
2026-03-10
Not yet open
Safety and Efficacy of Small Extracellular Vesicles Nebulizer in Patients With Allergic Rhinitis Complicated With Asthma
NCT07453771Allergic Rhinitis, Asthma
The Affiliated Hospital of Qingdao University
Not applicable
18
Guangzhou, Qingdao, Taiโ€™an, Chongqing
2026-03-05
Recruiting
A Study of DXC014 in Patients With Advanced Solid Tumors.
NCT07177937Small Cell Lung Cancer, Melanoma, Prostate Cancer, Other Advanced Solid Tumors
Hangzhou DAC Biotechnology Co., Ltd.
Phase 1
150
Beijing, Changsha, Nanchang, Qingdao, Hangzhou
2026-03-03
Recruiting
Downstaging and RATS After Neo-Chemo-IO: Impact on Surgical Outcomes in NSCLC
NCT07528066Neoadjuvant Chemoimmunotherapy, Robotic Pulmonary Resection, Stage IIB-III NSCLC
Shanghai Chest Hospital
Observational
200
Fuzhou, Guangzhou, Shenzhen, Nanjing, Qingdao, Tianjing, Shanghai
2026-03-02
Recruiting
A Study of BBT002 in Healthy Volunteers (HVs) and in Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) With or Without Comorbid Asthma
NCT07436949Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
Bambusa Therapeutics
Phase 1/2
64
Beijing, Guangzhou, Changsha, Nanjing, Jinan, Qingdao, Yantai, Zibo
2026-03-02
Not yet open
Study on the Safety and Efficacy of Intratympanic Injection of Small Extracellular Vesicles Derived From Mesenchymal Stem Cells in Severe and Profound Sudden Sensorineural Hearing Loss
NCT07404709Sudden Hearing Loss, Extracellular Vesicles
The Affiliated Hospital of Qingdao University
Phase 1/2
9
Guangzhou, Qingdao, Taiโ€™an, Chongqing
2026-02-28
Not yet open
PSMA-Targeted Intraoperative Fluorescent Imaging Agents (DGPR1008): Validation Across Different Time Windows
NCT07387510Prostate Cancer Patients Undergoing Radical Prostatectomy
Haitao Niu, MD
Phase 2
27
Qingdao
2026-02-27
Not yet open
Portal Vein Thrombosis in Cirrhosis: Incidence, Outcomes and Anticoagulation
NCT07422701Portal Vein Thrombosis, Liver Cirrhosis
Peking University First Hospital
Observational
2,522
Beijing, Shenzhen, Hengshui, Qinhuangdao, Wuxi, Qingdao
2026-02-01
Not yet open
Preventing Neurologic Complications in Valve Surgery
NCT07382362Left Atrial Appendage Closure
China National Center for Cardiovascular Diseases
Observational
100
Beijing, Qingdao, Shenzhen
2026-01-27
Active, closed
Time-Restricted Eating for Weight-Loss Maintenance
NCT07163455Overweight or Obese Adults
Harbin Medical University
Not applicable
500
Beijing, Chongqing, Shenzhen, Harbin, Xi'an, Qingdao, Weifang, Chengdu
2026-01-26
Active, closed
Safety, Tolerability, and Pharmacokinetics of Multiple-Dose RFUS-949 in Healthy Chinese Participants
NCT07676357Acute and Chronic Pain
The Affiliated Hospital of Qingdao University
Phase 1
28
Qingdao
2026-01-22
Recruiting
Prediction Model for MINS After Major Hepatobiliary Surgery
NCT07335042Myocardial Injury After Noncardiac Surgery (MINS), Postoperative Complications, Liver Neoplasm, Hepatobiliary Diseases
Beijing Tsinghua Chang Gung Hospital
Observational
1,800
Beijing, Chongqing, Qingdao, Shandong, Zhuhai
2026-01-14
Recruiting
Effect of Predictive Model on Double-Balloon Enteroscopy
NCT07288346Double-balloon Enteroscopy
Shandong University
Not applicable
338
Dezhou, Qingdao, Yantai, Zaozhuang, Jinan
2026-01-12
By invitation
Clinical Study on Using Laparoscopic Sentinel Lymph Node Navigation Combined With Dual Endoscopy Surgery for Early Gastric Cancer
NCT07708012Early-stage Upper Gastrointestinal Cancer, Stomach Cancer, Adenocarcinoma, Laparoscopy-assisted Surgery, Endoscope
wangdongsheng
Not applicable
30
Qingdao
2026-01-01
Not yet open
TACE Combined With Tislelizumab, Lenvatinib, and Carvedilol for Unresectable HCC With Cirrhotic Portal Hypertension
NCT07350070HCC, Liver Cirrhosis, Portal Hypertension
Tongji Hospital
Phase 2
78
Fuzhou, Nanning, Taihe, Wuhan, Jinan, Qingdao
2025-12-31
Recruiting
Assessing Iparomlimab and Tuvonralimab in Recurrent or Metastatic MSI-H/dMMR Gastric Cancer
NCT07127822Gastric / Gastroesophageal Junction Adenocarcinoma, MSI-H Cancer
Peking University
Phase 2
106
Shijiazhuang, Harbin, Zhengzhou, Nanjing, Xi'an, Qingdao, Taiyuan, Chengdu
2025-12-15
Recruiting
Multicenter Randomized Controlled Trial (RCT) and Efficacy Evaluation System Study on Surgical Innovation Strategies for Neonatal Complex Congenital Heart Disease
NCT07363538Complex Congenital Heart Disease
Central China Fuwai Hospital of Zhengzhou University
Not applicable
738
Beijing, Chongqing, Guangzhou, Zhengzhou, Wuhan, Changsha, Nanjing, Qingdao
2025-12-01
Recruiting
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
NCT07186101Ulcerative Colitis
Eli Lilly and Company
Phase 2
252
Changzhou, Chongqing, Fuzhou, Hangzhou, Kunming, Nanjing, Qingdao, Shenyang
2025-11-10
Recruiting
[18F]NIDF PET Imaging in Tau-related Diseases
NCT07306598Neurodegenerative Disease, Alzheimer s Disease, Tauopathies
Tianjin Medical University
Observational
20
Hefei, Qingdao, Tianjin
2025-11-01
Recruiting
Evaluation of the Safety and Effectiveness of CHORDSยฎ Cerebral Protection System During TAVR: DUET Trial
NCT07648693Transcatheter Aortic Valve Replacement (TAVR), Cerebral Vascular Accident (CVA)/Stroke
Resonova (Shanghai) Medtech Limited
Not applicable
240
Bengbu, Hefei, Beijing, Chongqing, Fuzhou, Guangzhou, Nanchang, Qingdao
2025-10-31
Not yet open
The Effects of Clostridium Butyricum on Adverse Events During Adjuvant Chemotherapy for Colorectal Cancer
NCT07152886Colorectal Cancer, Chemotherapeutic Toxicity
The Affiliated Hospital of Qingdao University
Phase 4
238
Qingdao
2025-10-31
Not yet open
Family-Supervised Prehabilitation to Reduce Postoperative Complications After Neoadjuvant Chemotherapy in Gastric Cancer
NCT07183358Stomach Neoplasms, Neoadjuvant Therapy
The Affiliated Hospital of Qingdao University
Not applicable
90
Qingdao
2025-09-20
Recruiting
Real-Time Diagnosis of Eosinophilic Nasal Polyps Using High-Sensitivity Spectroscopy
NCT07125586Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
The Affiliated Hospital of Qingdao University
Not applicable
353
Qingdao
2025-08-26
Recruiting
A Randomized Trial of Annular Repair With Discectomy Versus Discectomy Alone for Lumbar Disc Herniation
NCT07250581Lumbar Intervertebral Disc Herniation
The Affiliated Hospital of Qingdao University
Not applicable
300
Qingdao
2025-08-01
Not yet open
Study on Screening Strategies for Interstitial Lung Abnormalities and Airway Lesions
NCT07023575Interstitial Lung Abnormalities
China-Japan Friendship Hospital
Observational
100,000
Beijing, Shanghai, Changsha, Guiyang, Hangzhou, Henan, Qingdao, Shenyang
2025-08-01
Recruiting
Multimodal Imaging Assessment After Revascularization in Patients With Acute Myocardial Infarction
NCT07130409Cardiac Magnetic Resonance Imaging, Acute Myocardial Infarction (AMI), PET / MR
The Affiliated Hospital of Qingdao University
Observational
20
Qingdao
2025-08
Recruiting
Multimodal Imaging Assessment of Chronic Kidney Disease Patients at Different Stages From a Cardio-Renal Interaction Perspective
NCT07107919Chronic Kidney Disease, Cardiac Magnetic Resonance, 18F-FAPI
The Affiliated Hospital of Qingdao University
Observational
60
Qingdao
2025-07-30
Recruiting
[18F]FT8 PET Imaging in Immunoglobulin Light Chain Amyloidosis
NCT07232459Amyloid, Cardiac Amyloidosis, Amyloidosis, Healthy Subjects
Tianjin Medical University
Observational
25
Hefei, Qingdao, Tianjin
2025-07-21
Recruiting
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple-Ascending Doses of Tacabrutideg (BGB-16673) in Adults With Chronic Spontaneous Urticaria and in Healthy Participants
NCT07005713Chronic Spontaneous Urticaria
BeOne Medicines
Phase 1
58
Beijing, Chongqing, Guangzhou, Wuhan, Changsha, Qingdao, Chengdu, Hangzhou
2025-07-19
Recruiting
Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission
NCT06824168Acute Myeloid Leukemia, Leukemia
Daiichi Sankyo
Phase 2
130
Beijing, Changchun, Guangzhou, Hangzhou, Nanchang, Nanjing, Nanning, Qingdao
2025-07-18
Recruiting
A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma
NCT07069712Gastroesophageal Adenocarcinoma
AstraZeneca
Phase 2
100
Beijing, Changchun, Changzhi, Chengdu, Fuzhou, Hangzhou, Kunming, Qingdao
2025-07-17
Recruiting
Durvalumab as Consolidation Therapy in Patients With LS-SCLC Following sCRT
NCT07309211SCLC, Limited Stage
The First Affiliated Hospital with Nanjing Medical University
Observational
25
Jinan, Nanjing, Qingdao
2025-07-08
Recruiting
Bevacizumab Combined With Cisplatin Versus Cisplatin Monotherapy in Malignant Serous Effusions
NCT07090525Overall Response Rate
Qingdao Central Hospital
Phase 2
60
Qingdao
2025-07-01
Active, closed
Perioperative Treatment With TAS-102 in Combination With Oxaliplatin for Locally Advanced Rectal Cancer
NCT07090031EFS, pCR Rate
Qingdao Central Hospital
Phase 2
49
Qingdao
2025-07-01
Recruiting
Total Energy Expenditure in Healthy Chinese Populations: A Nationwide Study Using the Doubly Labelled Water Method
NCT07178054Healthy
Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences
Observational
240
Chongqing, Shenzhen, Haikou, Hohhot, Shenyang, Qingdao, Tacheng
2025-07-01
Not yet open
Pharmacokinetics and Pharmacodynamics Study
NCT07074236Primary Hypercholesterolemia or Combined Hyperlipidemia Characterized by Elevated LDL-C
Qilu Pharmaceutical Co., Ltd.
Phase 1
48
Qingdao
2025-07
Not yet open
BR Combined With OR in Treatment-naรฏve Marginal Zone Lymphoma
NCT07008053Marginal Zone Lymphomas
Tianjin Medical University Cancer Institute and Hospital
Phase 2
37
Fuzhou, Shijiazhuang, Changsha, Jinan, Qingdao, Tianjin
2025-07
Recruiting
Different Doses of Dalpicicl Combined With Letrozole in the First-line Treatment of HR-positive, HER2-negative Advanced Breast Cancer
NCT07285382HR Positive HER2 Negative Advanced Breast Cancer
wanghaibo
Phase 2
120
Dalian, Qingdao
2025-06-25
Not yet open
Chinese University Students' Death Attitudes and Their Initial Sandplay Characteristics
NCT07020143Death Attitude (Implicit/Explicit), Sandplay Therapy
Kai Huang
Observational
100
Qingdao
2025-06-20
Recruiting
An Observational Study on the Safety and Efficacy of Henagliflozin in Chinese Patients With Type 2 Diabetes
NCT06959030Type 2 Diabetes Mellitus (T2DM)
Second Affiliated Hospital of Guangxi Medical University
Observational
10,000
Beihai, Guilin, Nanning, Qingdao
2025-06-19
Recruiting
A Study to Evaluate the Safety and Efficacy of PN20 in the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure
NCT07446491Thrombocytopenia Associated With Chronic Liver Disease
Chongqing Peg-Bio Biopharm Co., Ltd.
Phase 1/2
54
Beijing, Chongqing, Guangzhou, Zhengzhou, Zhenjiang, Changchun, Chaozhou, Qingdao
2025-06-06
Recruiting
Cohort Observing Mechanisms, Progression and Sequelae of Valvular Heart Disease
NCT07267117Heart Valve Disease, Mitral Valve (MV) Regurgitation, Mitral Valve Disease, Mitral Valve Stenosis
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
10,000
Fuzhou, Wuhan, Changsha, Shenyang, Xi'an, Qingdao, Chengdu, รœrรผmqi
2025-06-01
Recruiting
Neoadjuvant Chemotherapy and PD-1 Inhibitor for Locally Advanced Rectal Cancer๏ผˆCONTROL-01๏ผ‰
NCT06647680Rectal Cancer Patients
The Affiliated Hospital of Qingdao University
Phase 2
35
Qingdao
2025-06-01
Not yet open
Comparison of ultraSound, Abbreviated MRI witH and Without HBP aS mOdalities for HCC suRveillance in patienTs With High Risk
NCT07010588Hepatocellular Carcinoma (HCC), Magnetic Resonance Imaging (MRI), Randomized Controlled Trial
Peking University People's Hospital
Not applicable
1,389
Beijing, Chongqing, Handan, Harbin, Wuhan, Changchun, Jinan, Qingdao
2025-06
Recruiting
HS-10542 Study in Healthy Participants
NCT07040046Healthy
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Phase 1
100
Qingdao
2025-05-16
Recruiting
Rapamycin-Eluting Vertebral Stents In The Real-World Treatment of Symptomatic Intracranial Atherosclerotic Stenosis
NCT07352852Intracranial Arterial Stenosis, Brain Diseases
The Affiliated Hospital of Qingdao University
Observational
300
Qingdao
2025-05-14
Active, closed
Carinaโ„ข Surgical Platform for Minimal Radical Gastrectomy
NCT07113340Robotic Gastrectomy, Stomach Neoplasms
The Affiliated Hospital of Qingdao University
Not applicable
20
Qingdao
2025-05-01
Recruiting
A Study of HS-20094 in Overweight or Obese Participants
NCT07057674Overweight or Obesity
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Phase 1
144
Qingdao
2025-04-16
Recruiting
Multicenter Study of 18F-Labeled NY104 for PET/CT Imaging in Renal Cell Carcinoma
NCT06916624Renal Cell Carcinoma (RCC), Clear Cell Renal Cell Carcinoma (ccRCC)
The Affiliated Hospital of Qingdao University
Observational
120
Qingdao
2025-04-12
Recruiting
Clinical Study of 18F-Labeled FAPI-04 in PET Imaging of Breast Cancer
NCT06916338Breast Cancer
The Affiliated Hospital of Qingdao University
Observational
30
Qingdao
2025-04-11
Recruiting
Clinical Study on the Application of 18F-HER2 Affibody PET Imaging in HER2-Expressing Breast Cancer
NCT06916637Breast Cancer, Breast Cancer, HER2-Expression
The Affiliated Hospital of Qingdao University
Observational
40
Qingdao
2025-04-09
Recruiting
Efficacy and Safety of SLIT in Patients With Rhinitis/RC With/Without Mild-moderate Asthma, Due to Dpt and/or Df
NCT07348302Rhinitis, Rhinoconjunctivitis
Inmunotek S.L.
Phase 3
736
Beijing, Guangzhou, Zhongshan, Xiangya, Changzhou, Qingdao, Shanghai, Tongji
2025-04-02
Recruiting
Effect of the Home-based Digital-assisted Dyadic Tai Chi (HDTC) Training Program Among Sedentary Individuals With HF and Their Caregivers: a Randomized Controlled Trial
NCT06876441Heart Failure (HF)
The Hong Kong Polytechnic University
Not applicable
256
Qingdao
2025-04-01
Recruiting
Alpha-Synuclein PET/CT in Various ฮฑ-Syn-Related Disease
NCT06949670Alpha Synuclein Pathology, Alpha-Synuclein, Parkinson Disease
Tianjin Medical University
Observational
500
Hefei, Qingdao, Tianjin
2025-04-01
Not yet open
Deep Sedation in Catheter Ablation of Atrial Fibrillation
NCT06836999Atrial Fibrillation, Atrial Fibrillation, Paroxysmal or Persistent, Deep Sedations, Conscious Sedation
The First Affiliated Hospital of Dalian Medical University
Not applicable
1,334
Hefei, Guangzhou, Nanjing, Suzhou, Nanchang, Dalian, Qingdao, Shanghai
2025-03-03
Not yet open
A Single-center, Open, Randomized, Single-dose, Cross-over Bioequivalence Study to Evaluate the Effects of the Test Formulation Abalparatide Injection and the Reference Formulation Abalparatide Injection (Tymlosยฎ) in Healthy Adult Subjects
NCT06753864Osteoporosis
The Affiliated Hospital of Qingdao University
Phase 1
32
Qingdao
2025-01-02
Recruiting
Osimertinib Combined With Savolitinib in the Treatment of NSCLC With Low Copy Number MET Amplification
NCT07322783EGFR Positive Non-small Cell Lung Cancer, MET Amplification
Qingdao Central Hospital
Phase 2
60
Qingdao
2025-01-01
Recruiting
Study on Human Bioequivalence of Triprerelin Acetate for Injection
NCT06683066Prostate Cancer (CRPC)
The Affiliated Hospital of Qingdao University
Phase 1
120
Qingdao
2024-12-04
Active, closed
A Real-world Study to Assess Safety of OZURDEXยฎ (Dexamethasone Intravitreal Implant) in Adult Participants With Diabetic Macular Edema in China
NCT06548568Diabetic Macular Edema
AbbVie
Observational
110
Beijing, Xiamen, Guangzhou, Zhengzhou, Wuhan, Dalian, Xi'an, Qingdao
2024-11-13
Recruiting
Digital Early Warning System for Acute Lung Injury in Liver Surgery
NCT07070362Acute Lung Injury(ALI), Liver Cirrhosis, ARDS, Human, MASLD
Beijing Tsinghua Chang Gung Hospital
Observational
3,000
Beijing, Chongqing, Qingdao
2024-11-01
Recruiting
First-line Treatment With RC48 Plus Sintilimab and S-1 in Advanced Gastric Cancer (RCTS2)
NCT06730373HER2-positive Gastric Cancer, Metastatic Gastric Cancer, Unresectable Gastric Carcinoma
Qilu Hospital of Shandong University
Phase 2
110
Zhengzhou, Binzhou, Dongying, Jinan, Jining, Liaocheng, Linyi, Qingdao
2024-10-17
Recruiting
A Research Protocol for Evaluating the Efficacy of Perfused Chemotherapeutic Agents for Bladder Cancer Based on Organoid Technology
NCT06662071Bladder Cancer
Qilu Hospital of Shandong University
Observational
293
Binzhou, Dezhou, Jinan, Jining, Liaocheng, Linyi, Qingdao, Taian
2024-10-01
Recruiting
Efficacy and Safety of PJ009 in Patients With Short Bowel Syndrome Requiring Parenteral Nutrition
NCT06512584Short Bowel Syndrome
Chongqing Peg-Bio Biopharm Co., Ltd.
Phase 3
72
Beijing, Chongqing, Guangzhou, Changsha, Nanjing, Qingdao, Shanghai, Xiโ€™an
2024-09-03
Active, closed
MRI Assessment of Pancreatic Fat Changes and Islet Function Recovery After Bariatric Surgery in Obese Patients
NCT07464223Obesity & Overweight, Type 2 Diabetes Mellitus (T2DM), Pancreatic Steatosis, Insulin Resistance
yu li๏ผŒMD
Observational
50
Qingdao
2024-09-01
Recruiting
A Study of Intravesical FL115 Alone or in Combination With BCG in Non-Muscle Invasive Bladder Cancer
NCT07122414Non-muscle Invasive Bladder Cancer (NMIBC)
Suzhou Forlong Biotechnology Co., Ltd
Phase 1/2
80
Beijing, Fuzhou, Wenzhou, Changsha, Nanjing, Suzhou, Qingdao, Chengdu
2024-08-16
Recruiting
A Clinical Study of B007 in the Treatment of Primary Membranous Nephropathy.
NCT06470191Primary Membranous Nephropathy
Shanghai Jiaolian Drug Research and Development Co., Ltd
Phase 2/3
216
Beijing, Changchun, Guangzhou, Hangzhou, Jinan, Nanning, Nantong, Qingdao
2024-07-30
Not yet open
Effect and Safety of Huaier Granule Versus SOX Regimen in Gastric Cancer Patients
NCT05498766Gastric Cancer
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 4
702
Wuhan, Qingdao
2024-07-01
Active, closed
A Study of the Efficacy, Safety, and Pharmacokinetics (PK) of the Port Delivery System With Ranibizumab (PDS) in Chinese Participants With Neovascular Age-related Macular Degeneration (nAMD)
NCT05562947Neovascular Age-related Macular Degeneration, nAMD
Hoffmann-La Roche
Phase 3
68
Beijing, Chengdu, Guangzhou, Harbin, Qingdao, Shanghai, Shenyang, Taiyuan
2024-06-17
Active, closed
Effect of Intraperitoneal Drain Placement on Postoperative Outcomes Following Laparoscopic Appendectomy in Adult Patients With Perforated Appendicitis
NCT06927765Perforated Appendicitis
The Affiliated Hospital of Qingdao University
Observational
500
Qingdao
2024-06-01
Recruiting
Nutrition Impact on Immunotherapy of Cancer
NCT06500234Nutrition Disorders, Immunotherapy, Cancer, Survival, Prosthesis
Qingdao Central Hospital
Phase 3
300
Qingdao
2024-06-01
Rows per page Showing 1–100 of 165
1 2 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-china/city/qingdao

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 165 of those studies with a site in Qingdao.

How many clinical trials are recruiting in Qingdao?

88 of the 165 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 36 have not yet opened recruitment, 38 are active but closed to new participants, and 3 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Qingdao), 165 studies
PhaseStudiesRecruitingShare
Observational574234.5%
Not applicable331120%
Phase 2221213.3%
Phase 320612.1%
Phase 11689.7%
Phase 4724.2%
Phase 1/2643.6%
Phase 2/3331.8%
Phase EARLY_PHASE1100.6%

Most active sponsors

Lead sponsors with the most studies (Qingdao)
Lead sponsorStudiesRecruiting
The Affiliated Hospital of Qingdao University3014
Tianjin Medical University1717
Qilu Hospital of Shandong University72
Qingdao Central Hospital75
Alexion Pharmaceuticals, Inc.31
Jiangsu Hansoh Pharmaceutical Co., Ltd.32
Shandong University32
AbbVie20
Actelion21
AstraZeneca21
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.